Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Expert Review of Pharmacoeconomics & Outcomes Research|September 16, 2021
Analysis of patients' access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and GreeceYoana Seitaridou, Ivo Tsekov, Maria Kamusheva, et al.
Frontiers in Public Health|March 21, 2018
An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European CountriesMaria Kamusheva, Mariya Vassileva, Alexandra Savova, et al.
Pharmacy Practice|August 23, 2014
The applicability of the tetraclass model to the management of the patient satisfaction in the pharmaciesGuenka Petrova, Fabrice Clerfeuille, Milena Vakrilova, et al.
SAGE Open Medicine|June 18, 2020
Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countriesMaria Dimitrova, Dragana Lakic, Guenka Petrova, et al.
Croatian Medical Journal|February 22, 2012
Pharmacy network and access to medicines in selected eastern European countries: comparative analysisDragana Lakić, Ljiljana Tasić, Mitja Kos, et al.
Rheumatology International|June 27, 2022
Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapiesVladimira Boyadzhieva, Konstantin Tachkov, Nikolay Stoilov, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 23, 2019
Historical overview of regulatory framework development on pricing and reimbursement of medicines in BulgariaMaria Vassileva, Maria Kamusheva, Manoela Manova, et al.
Frontiers in Public Health|September 25, 2020
Comparison of Cardiovascular Medicines Prices in Four European CountriesZornitsa Mitkova, Mariya Vasileva, Alexandra Savova, et al.
BMC Health Services Research|November 29, 2019
Аn affordability of statins therapy - comparative analysis between Ukraine and BulgariaOksana Tkachova, Larysa Iakovlieva, Zornitsa Mitkova, et al.
SAGE Open Medicine|February 24, 2017
Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapyGuenka Petrova, Assena Stoimenova, Maria Dimitrova, et al.
Pageof 11